→
Centene Corp
Centene Corp (CNC) currently trades at $37.3, down 0.67% from the previous close of $37.55, with a market cap of $18.34B. Despite a robust revenue growth of 19.44% YoY, the stock's Price-to-Sales ratio stands at a mere 0.09, indicating significant undervaluation, yet the negative ROE of -27.74% raises concerns about profitability. Analysts show mixed sentiments with 3 Strong Buy and 16 Hold ratings, reflecting uncertainty in the stock's future performance.
Given the mixed signals from growth potential and profitability concerns, I recommend holding CNC for now while monitoring upcoming earnings and strategic developments.
Can UnitedHealth Ease Margin Pressure on CMS Tailwinds?
2026-04-10
CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL
2026-04-10
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
2026-04-10
Centene’s North Carolina Merger Tests Scale Benefits And Undervalued Thesis
2026-04-09
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes your holdings, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates CNC as Neutral. Given the mixed signals from growth potential and profitability concerns, I recommend holding CNC for now while monitoring upcoming earnings and strategic developments.
However, the negative ROE of -27.74% indicates ongoing issues with profitability, which could deter investors. Additionally, the mixed analyst consensus, with 16 Hold ratings, suggests that the market lacks confidence in a quick turnaround, and volatility could persist.
If Centene can maintain its impressive revenue growth of 19.44% YoY and successfully navigate its operational challenges, it could see a recovery towards its 52-week high of $64.15. Furthermore, the stock's low P/S ratio of 0.09 suggests it is significantly undervalued compared to its peers in the health care sector.
Centene Corp (CNC) currently trades at $37.3, down 0.67% from the previous close of $37.55, with a market cap of $18.34B. Despite a robust revenue growth of 19.44% YoY, the stock's Price-to-Sales ratio stands at a mere 0.09, indicating significant undervaluation, yet the negative ROE of -27.74% raises concerns about profitability. Analysts show mixed sentiments with 3 Strong Buy and 16 Hold ratings, reflecting uncertainty in the stock's future performance.
Centene Corp (CNC) currently trades at $37.3, down 0.67% from the previous close of $37.55, with a market cap of $18.34B. Despite a robust revenue growth of 19.44% YoY, the stock's Price-to-Sales ratio stands at a mere 0.09, indicating significant undervaluation, yet the negative ROE of -27.74% raises concerns about profitability. Analysts show mixed sentiments with 3 Strong Buy and 16 Hold ratings, reflecting uncertainty in the stock's future performance. Our overall verdict is Neutral.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for CNC at helmterminal.dev/analyze/CNC, updated continuously during US market hours. No signup required.